Aroa Biosurgery (ASX:ARX) Land And Improvements: A$ Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:ARX Aroa Biosurgery Ltd ASX:ARX
57 GF Score
Price A$0.52
GF Value A$0.88
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is Aroa Biosurgery Land And Improvements?

Aroa Biosurgery ASX:ARX -1.89% 57 Land And Improvements is A$ Mil as of Mar. 2026. GuruFocus rates ASX:ARX with a GF Score™ of 57/100 and a GF Value™ of A$0.88 (Significantly Undervalued). The stock has 1 warning sign investors should review.

Aroa Biosurgery's land and improvements for the quarter that ended in Mar. 2026 was A$ Mil.

Aroa Biosurgery Land And Improvements Historical Data

* Premium members only.

The historical data trend for Aroa Biosurgery's Land And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aroa Biosurgery Land And Improvements Chart

Aroa Biosurgery Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Land And Improvements
Get a 7-Day Free Trial Premium Member Only - - - - -

Aroa Biosurgery Semi-Annual Data
Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Land And Improvements Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -
ASX:ARX
57GF Score
Aroa Biosurgery Ltd ASX:ARX
Land And Improvements is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aroa Biosurgery Land And Improvements Calculation

Land is the surface or crust of the earth, which can be used to support structures, and may be used to grow crops, grass, shrubs, and trees. Land is characterized as having an unlimited life (indefinite). Land improvement is a long-term asset which indicates the cost of the constructed improvements to land, such as driveways, walkways, lighting, and parking lots.

Frequently Asked Questions Learn more about Land And Improvements →
What does a Land And Improvements of A$ Mil mean?
Aroa Biosurgery (ASX:ARX) has a Land And Improvements of A$ Mil as of Mar. 2026. Land and improvements records the total value of a company's land and improvements to it. View historical data on Aroa Biosurgery and its competitors.
Is Aroa Biosurgery's Land And Improvements too high?
Aroa Biosurgery's current Land And Improvements is A$ Mil. Overall, Aroa Biosurgery has a GF Score™ of 57/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Aroa Biosurgery's Land And Improvements compare to ABT and SYK?
Aroa Biosurgery's Land And Improvements of A$ Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Land And Improvements for a Medical Devices & Instruments company?
A good Land And Improvements depends on the Medical Devices & Instruments industry context. However, Land And Improvements should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Land And Improvements mean?
A high Land And Improvements can signal that a stock is expensive relative to its fundamentals. Land and improvements records the total value of a company's land and improvements to it. View historical data on Aroa Biosurgery and its competitors. Aroa Biosurgery's current Land And Improvements is A$ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aroa Biosurgery stock overvalued right now?
Based on GuruFocus' analysis, Aroa Biosurgery (ASX:ARX) is currently considered Significantly Undervalued. The stock's GF Value™ is A$0.88, compared to a current price of A$0.52 — trading 40.9% below its estimated fair value. The current Land And Improvements is A$ Mil. Aroa Biosurgery's overall GF Score™ is 57/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Land And Improvements calculated?
Land And Improvements is calculated from a company's financial statements. For Aroa Biosurgery (ASX:ARX), the current Land And Improvements is A$ Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Aroa Biosurgery (ASX:ARX) Overvalued in 2026?

Based on GuruFocus' analysis, Aroa Biosurgery stock appears to be undervalued. The current stock price of A$0.52 is trading 40.9% below its estimated GF Value™ of A$0.88. GuruFocus considers Aroa Biosurgery to be Significantly Undervalued.

Key valuation signals for ASX:ARX:

  • Land And Improvements: A$ Mil
  • GF Value™: A$0.88 vs. price of A$0.52 (40.9% below fair value)
  • GF Score™: 57/100 with 1 warning sign

No single metric tells the full story. See the ASX:ARX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Aroa Biosurgery Business Description

Other Exchanges AROAF:USA
Address 64 Richard Pearse Drive, Mangere, Airport Oaks, Auckland, NZL, 2022
Aroa Biosurgery Ltd is a soft tissue regeneration company that develops, manufactures, and sells medical devices for wound and soft tissue repair using its proprietary extracellular matrix (ECM) technology. It is focused on improving the rate and quality of healing in complex wounds and soft tissue reconstruction. The company is in the business of developing, manufacturing, and selling soft tissue repair products. The company's principal market is the United States, where it has five key products for sale targeting chronic wounds, hernia, plastics, reconstructive surgery, and trauma/limb salvage/tumor surgery.
57GF Score

Get the complete analysis for ASX:ARX

Land And Improvements is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.52
Price
A$0.88
GF Value